缔码生物科技有限公司是一个专注于肿瘤免疫产品和服务的重组单克隆抗体研发公司。公司拥有的DimAb®重组单克隆抗体技术，可以获得多种属、高质量的单克隆抗体。公司研发团队具备多年的单克隆抗体开发经验，并获得业界广泛认可。公司致力于肿瘤免疫靶标单克隆抗体的研发和生产，为全球的科学研究、临床诊断和药物研发提供方位的解决方案。 公司的企业文化是诚信，务实，创新，专注。公司的使命是应用先进的生物技术为癌症的诊断和治疗提供全新有效的解决方案。
dimabio2021年价格表
| 货号 | 品名 | 规格 | 价格 | 品牌 |
| DME100001 | Anti-His Tag Antibody(DM1), Rabbit mAb | 100 μl | 2680 | dimabio2021 |
| DME100004 | Anti-BCMA antibody(DM4), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100006 | Anti-BCMA antibody(DM6), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100008 | Anti-SIRPα antibody(DM8) , Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100009 | Anti-CS1 antibody(DM9)， Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100010 | Anti-CS1 antibody(DM10)， Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100011 | Anti-CS1 antibody(DM11)， Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100013 | Anti-CD22 antibody(DM13), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100015 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM22), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100016 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM23), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100017 | Anti-SARS-CoV-2 Spike S2 antibody(DM24), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100018 | Anti-SARS-CoV-2 Spike S2 antibody(DM25), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100025 | Anti-SARS-CoV-2 RBD antibody(DM26), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100026 | Anti-SARS-CoV-2 RBD antibody(DM27), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100020 | Anti-BCMA antibody(DM16), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100027 | Anti-CD38 antibody(DM28), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100028 | Anti-CD38 antibody(DM29), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100029 | Anti-CD38 antibody(DM30), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100034 | Anti-SARS-CoV-2 RBD antibody(DM35), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100030 | Anti-CD123 antibody(DM31), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100032 | Anti-CD123 antibody(DM33), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100033 | Anti-CD123 antibody(DM34), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100035 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM36), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100036 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM37), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100037 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM38), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100038 | Anti-SARS-CoV-2 Spike antibody(DM39), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100039 | Anti-SARS-CoV-2 Spike antibody(DM40), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100040 | Anti-SARS-CoV-2 Spike antibody(DM41), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100041 | Anti-SARS-CoV-2 Spike antibody(DM42), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100042 | Anti-CD48 antibody(DM43), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100043 | Anti-CD48 antibody(DM44), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100044 | Anti-CD138 antibody(DM45), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100045 | Anti-CD138 antibody(DM46), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100046 | Anti-ACE2 antibody(DM47), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100047 | Anti-ACE2 antibody(DM48), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100048 | Anti-CD47 antibody(DM49), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100049 | Anti-CTLA4 antibody(DM50), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100050 | Anti-CTLA4 antibody(DM51), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100052 | Anti-GITR-L antibody(DM52), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100053 | Anti-B7-H3 antibody(DM53), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100057 | Anti-CD27 antibody(DM57), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100058 | Anti-CD27 antibody(DM58), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100059 | Anti-CD27 antibody(DM59), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100060 | Anti-GPRC5D antibody(DM60), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100061 | Anti-GPRC5D antibody(DM61), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100062 | Anti-GPRC5D antibody(DM62), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100063 | Anti-CD28 antibody(DM63), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100064 | Anti-CD28 antibody(DM64), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100069 | Anti-2B4 antibody(DM69), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100054 | Anti-SARS-CoV-2 RBD antibody(DM54), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100055 | Anti-SARS-CoV-2 RBD antibody(DM55), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100056 | Anti-CD138 antibody(DM56), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100068 | Anti-4-1BB Ligand antibody(DM68), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100070 | Anti-2B4 antibody(DM70), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100071 | Anti-MSLN antibody(DM71), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100072 | Anti-MSLN antibody(DM72), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100073 | Anti-MSLN antibody(DM73), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100066 | Anti-4-1BB antibody(DM66), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100067 | Anti-4-1BB antibody(DM67), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100074 | Anti-Trop2 antibody(DM74), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100075 | Anti-Trop2 antibody(DM75), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100076 | Anti-Trop2 antibody(DM76), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100077 | Anti-CD33 antibody(DM77), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100078 | Anti-GITR antibody(DM78), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100079 | Anti-GITR antibody(DM79), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100080 | Anti-GITR antibody(DM80), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100084 | Anti-B7-2 antibody(DM84), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100085 | Anti-B7-2 antibody(DM85), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100086 | Anti-B7-2 antibody(DM86), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100087 | Anti-PSCA antibody(DM87), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100088 | Anti-NKp30 antibody(DM88), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100081 | Anti-TIM3 antibody(DM81), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100082 | Anti-TIM3 antibody(DM82), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100083 | Anti-TIM3 antibody(DM83), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100089 | Anti-GPRC5D antibody(DM89), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100090 | Anti-GPRC5D antibody(DM90), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| BME100001 | Anti-CD47 (magrolimab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100002 | Anti-CS1 (elotuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100003 | Anti-CD123 (talacotuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100004 | Anti-CD38 (daratumumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100005 | Anti-CD70 (vorsetuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100006 | Anti-PD-1 (pembrolizumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100007 | Anti-IL6 (siltuximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100008 | Anti-TIM3 (cobolimab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100009 | Anti-PDL1 (atezolizumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100010 | Anti-B7-H3 (enoblituzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100011 | Anti-SARS-CoV-2 (CB6 biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100012 | Anti-ICOS (vopratelimab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100013 | Anti-SARS-CoV (CR3022) mAb | 100 μl | 1500 | dimabio2021 |
| BME100014 | Anti-CD138 (indatuximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100015 | Anti-CD33 (gemtuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100018 | Anti-CD27 (varlilumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100019 | Anti-EPHA3 (ifabotuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100016 | Anti-BCMA mAb | 100 μl | 1500 | dimabio2021 |
| BME100017 | Anti-CD30 (brentuximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100020 | Anti-CD40 (iscalimab biosimilar)mAb | 100 μl | 1500 | dimabio2021 |
| BME100021 | Anti-MSLN(amatuximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100022 | Anti-CTLA4 (ipilimumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100023 | Anti-Trop2 (sacituzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100024 | Anti-TIGIT (etigilimab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100038 | Anti-IL17RA (brodalumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100039 | Anti-NKG2D (tesnatilimab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100040 | Anti-CA9 (girentuximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100025 | Anti-CD20 (rituximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100026 | Anti-TIGIT (tiragolumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100027 | Anti-TIGIT (vibostolimab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100028 | Anti-BCMA ( belantamab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100034 | Anti-EGFR (Cetuximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100033 | Anti-AXL (enapotamab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100032 | Anti-TNFRSF10B (tigatuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100031 | Anti-TweakR (enavatuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100030 | Anti-CD52 (alemtuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100029 | Anti-CD22 (pinatuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100035 | Anti-CEACAM5 (labetuzumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100036 | Anti-ICAM1 (bersanlimab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100037 | Anti-4-1BB (utomilumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100041 | Anti-IL6R (tocilizumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100042 | Anti-CD40L (ruplizumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100043 | Anti-IL2RA (basiliximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100044 | Anti-BAFF (belimumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100045 | Anti-BAFFR (ianalumab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100046 | Anti-CD37 (naratuximab biosimilar) mAb | 100 μl | 1500 | dimabio2021 |
